US Patent 11602544 Compositions and methods for treating EGFR positive cancers
All edits
Edits on 4 Apr, 2023
Golden AI
Edits on 28 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116025440
Date of Patent
March 14, 2023
0Patent Application Number
176637580
Date Filed
May 17, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 15 Mar, 2023
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+174 characters)
US Patent 11602544 Compositions and methods for treating EGFR positive cancers
Article
The disclosure provides immune cells comprising a first activator receptor and a second inhibitory receptor, and methods of making and using same for the treatment of cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116025440
Date of Patent
March 14, 2023
0Patent Application Number
176637580
Date Filed
May 17, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11602544 Compositions and methods for treating EGFR positive cancers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.